ASCO 2023: Solid Tumors

Coverage of clinical trial results presented across a range of solid tumor cancers, including breast, ovarian, colorectal, and non-small cell lung cancer, among other types; as well as important findings in genomic testing.

Related Keywords

United States ,Japan ,Australia ,University Of Chicago ,Illinois ,Germany ,New Haven ,Connecticut ,China ,Peking ,Beijing ,California ,Singapore ,National Taiwan University ,T Ai Pei ,Taiwan ,Tennessee ,Corrs ,Texas ,Long Wu ,Hubei ,Guangdong ,Jilin ,San Antonio ,South Korea ,Chicago ,Chinese ,American ,Alpha Biopharma ,Jie Wang ,Dennisj Slamon ,Debra Patt ,Dennis Slamon ,Borisa Hadaschik ,Roys Herbst ,Rita Nanda ,Bradley Alexander Mcgregor ,Nathan Pennell ,Qing Zhou ,Andrew Hertler ,Mengzhao Wang ,Daiichi Sankyo ,Awny Farajallah ,Jonathanw Riess ,Tus Fruquintinib ,Eli Lilly ,James Yang ,American Society Of Clinical Oncology Annual Meeting ,Novartis ,Century Health ,University Of Duisburg ,Solutions In Treating ,Department Of Medicine ,Dana Farber Cancer Institute ,Department Of Urology ,University Medical College ,National Institutes Of Health ,Caffreym New Century Health Andrew Hertler ,Us Preventive Services Task ,Department Of Investigational Cancer Therapeutics ,Institute Of Oncology ,E Committee Members ,National Comprehensive Cancer Network ,Sciences Corp ,Devices Agency ,National Taiwan University Cancer Center ,European Society Of Medical Oncology ,Essen University Hospital ,National Cancer Institute ,International Society Of Urologic Pathologists ,Takeda Pharmaceuticals ,Ovarian Cancer Research Alliance ,San Antonio Breast Cancer Congress ,University Of California ,Yale School Of Medicine ,American Society Of Clinical Oncology ,Guangdong Lung Cancer Institute ,Division Of Hematology Oncology ,Vanderbilt University Medical Center ,Cancer Center ,Chinese Academy Of Medical Science ,American Society Of Clinical Oncology Cancer ,American Cancer Society ,Yale Cancer Center ,Lung Cancer Medical Oncology Program ,University Of Texas Md Anderson Cancer Center ,Astrazeneca ,University Of Texas At Austin ,European Medicines Agency ,Expressing Cancers Across Multiple Tumor ,American Society ,Clinical Oncology ,Annual Meeting ,Funda Meric Bernstam ,Investigational Cancer Therapeutics ,Evidence Based Oncology ,New Century Health ,Patients Whose Cancers Were Detected With ,Are Cancer Free ,Exact Sciences ,Durvalumab Improved ,Patients Newly Diagnosed With Advanced Ovarian ,Updated May ,Cancer Research ,Accessed June ,Most Common Type ,National Institutes ,New England Journal ,What Sets ,Older Patients With ,Early Breast Cancer ,Dosing Management ,Gynecologic Cancer Research Program ,Sarah Cannon Research Institute ,Antonio Breast Cancer Congress ,More Comorbidities Among Older ,Texas Oncology ,Abemaciclib Combined With Endocrine Therapy ,Adjuvant Treatment ,Patients With Resected ,Yale School ,Cleveland Clinic Taussig Cancer ,New Solutions ,Clinical Oncology Annual ,Comprehensive Cancer Center ,Graduate Institute ,Peking University Medical College ,Chinese Academy ,Medical Science ,Breakthrough Therapy ,American Cancer ,Revised January ,Hold Prognostic Utility ,Clinical Oncology Annual Meeting ,International Society ,Urologic Pathologists ,Priority Review ,Confirm Safety ,European Society ,Medical Oncology ,Medical Devices Agency ,Prescription Drug User Fee ,Services Task Force ,New Drug Application ,University Medical ,